LBF20306PG01: Difference between revisions
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
|UV Spectra=<FONT FACE="Symbol">l</FONT>max=296nm <FONT FACE="Symbol">e</FONT>296=18300 | |UV Spectra=<FONT FACE="Symbol">l</FONT>max=296nm <FONT FACE="Symbol">e</FONT>296=18300 | ||
|Chromatograms=PGD2 and other metabolites are separated with HPLC. Please reffer following paper.[[Reference:Soderstrom_M:Wigren_J:Surapureddi_S:Glass_CK:Hammarstrom_S:,Biochim. Biophys. Acta,2003,1631,35|{{RelationTable/GetFirstAuthor|Reference:Soderstrom_M:Wigren_J:Surapureddi_S:Glass_CK:Hammarstrom_S:,Biochim. Biophys. Acta,2003,1631,35}}]] | |Chromatograms=PGD2 and other metabolites are separated with HPLC. Please reffer following paper.[[Reference:Soderstrom_M:Wigren_J:Surapureddi_S:Glass_CK:Hammarstrom_S:,Biochim. Biophys. Acta,2003,1631,35|{{RelationTable/GetFirstAuthor|Reference:Soderstrom_M:Wigren_J:Surapureddi_S:Glass_CK:Hammarstrom_S:,Biochim. Biophys. Acta,2003,1631,35}}]] | ||
|Source= | |||
|Chemical Synthesis= | |||
|Metabolism=15-deoxy-<FONT FACE="Symbol">D</FONT><SUP><FONT SIZE=-1>1</FONT></SUP><SUP><FONT SIZE=-1>2</FONT></SUP><SUP><FONT SIZE=-1>.</FONT></SUP><SUP><FONT SIZE=-1>1</FONT></SUP><SUP><FONT SIZE=-1>4</FONT></SUP>-Prostaglandin D2 is formed from Prostaglandin D2 via <FONT FACE="Symbol">D</FONT><SUP><FONT SIZE=-1>1</FONT></SUP><SUP><FONT SIZE=-1>2</FONT></SUP>-Prostaglandin D2. This reaction is proceeded under co-culture with Prostaglandin D2 and serum.[[Reference:Soderstrom_M:Wigren_J:Surapureddi_S:Glass_CK:Hammarstrom_S:,Biochim. Biophys. Acta,2003,1631,35|{{RelationTable/GetFirstAuthor|Reference:Soderstrom_M:Wigren_J:Surapureddi_S:Glass_CK:Hammarstrom_S:,Biochim. Biophys. Acta,2003,1631,35}}]];> | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 07:00, 25 November 2009
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1733 |
| LipidMaps | LMFA03010051 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20306PG01 |
| 15-deoxy-Δ12.14-Prostaglandin D2 | |
|---|---|
| |
| Structural Information | |
| 9α-hydroxy-11-oxo-prosta-5Z,12E,14E-trien-1-oic acid | |
| |
| Formula | C20H30O4 |
| Exact Mass | 334.21440944799997 |
| Average Mass | 334.4498 |
| SMILES | C([C@H]1CC=CCCCC(O)=O)(C(C[C@@H]1O)=O)=CC=CCCCCC |
| Physicochemical Information | |
| 15-deoxy-D12.14-Prostaglandin D2 is formed from Prostaglandin D2 via D12-Prostaglandin D2. This reaction is proceeded under co-culture with Prostaglandin D2 and serum. Soderstrom_M et al.;> | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | lmax=296nm e296=18300 |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | PGD2 and other metabolites are separated with HPLC. Please reffer following paper. SoderstromMet al. |
| Reported Metabolites, References | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
